Glypican 2 As A Cancer Marker And Therapeutic Target
Australia
2023278110
Filed on 2023-12-08
2023278110
Filed on 2023-12-08
ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY
US Application 19/356,663
Filed on 2025-10-13
Filed on 2025-10-13
METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY
European Patent
21801948.7
Filed on 2023-06-05
21801948.7
Filed on 2023-06-05
METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY
China
202180089310.3
Filed on 2023-07-05
202180089310.3
Filed on 2023-07-05
METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY
Japan
2023-550709
Filed on 2023-05-08
2023-550709
Filed on 2023-05-08
SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF
US Application 19/482,967
Filed on 2025-11-10
Filed on 2025-11-10
EXPRESSION VECTORS FOR ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
United Kingdom
19217074.4
Filed on 2019-12-17
19217074.4
Filed on 2019-12-17
EXPRESSION VECTORS FOR ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
Germany
19217074.4
Filed on 2019-12-17
19217074.4
Filed on 2019-12-17
EXPRESSION VECTORS FOR ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
France
19217074.4
Filed on 2019-12-17
19217074.4
Filed on 2019-12-17
INTEGRASE STRAND TRANSFER INHIBITORS HAVING
STRUCTURES OF PHENYL OR ARYL SUBSITTUTION AT THE 6-POSITION OF A 1-HYDROXY-1, 8-NAPHTHYRIDIN2(1H)-ONE BASED METAL CHELATING
Patent Cooperation Treaty
PCT/US2025/051090
Filed on 2025-10-15
PCT/US2025/051090
Filed on 2025-10-15